InvestorsHub Logo
Followers 1
Posts 66
Boards Moderated 0
Alias Born 09/27/2021

Re: None

Tuesday, 04/12/2022 6:49:37 AM

Tuesday, April 12, 2022 6:49:37 AM

Post# of 6485
Pharmagreen Biotech Inc. Revenue Projections - 5 Year Financial Projections Summary




* For 2022, the greenhouse will be under construction, takes approximately five months to build and a crop every two months.
Each greenhouse will produce approximately $9,000,000 annually at capacity. One greenhouse is expected to be added annually until 2025.
Additional land needs to be acquired for subsequent greenhouses.

** Tissue Culture Facility is projected to be operational by 2023 with 3,600,000 plantlets produced at full capacity by 2025
For 2023 50% Capacity, for 2024 75% Capacity, for 2025 100% Capacity Tissue Culture Biotech Complex
Assumptions:
Plantlets current market price $12
COGS w. 3% contingency build in $12
Operating expenses 20%

*** Other Potential Income will be derived from Live Rosin Sales at $18,000 /day gross revenue.

**** Acquistion of Long Valley Farms. LLC in California for $1,200,000 in cash.

***** Ten million dollars is estimated cost for more land to expand the greenhouses.




So, does this read as a roadmap toward $0.35 share price to anyone else?